Cross-condition Validation of the Steroid PRO

Status Recruiting

Clinical Trial Summary

Testing a questionnaire about treatment with steroids for skin, lung or gastric conditions

Clinical Trial Description

Glucocorticoid drugs, also known as 'steroids', are used to treat a range of diseases. It is well-known that steroids can cause many unwanted side-effects. The investigators are interested in measuring the impact of steroids on quality of life, from the patients' perspective. In a previous part of this study, the investigators interviewed participants treated with steroids for a range of rheumatic conditions. The participants were asked how taking steroids affects their everyday lives. A patient questionnaire (the 'Steroid PRO') was then created focused on the topics identified as being most important to participants. Now the investigators would like to test this questionnaire with new participants, aged 18 or over, who are taking steroids for other conditions. This could include participants who have inflammation in the lungs, skin, or bowels. The investigators will also ask for feedback from the medical teams who care for those who have these conditions. The study involves a single interview with a researcher, either online or by telephone. Participants who want to take part will be given information about the study and asked to give written consent. Participants will be asked to talk about the wording of the questionnaire and how relevant and feasible it is to them. This part of the study is funded by Sanofi Research and Development. The work is being carried out by independent researchers at the University of the West of England (UWE, Bristol). Participants will be recruited from hospitals in the UK and USA. The investigators hope that the Steroid PRO questionnaire will be used in future research trials about steroid treatment and alternatives to steroids. The Steroid PRO questionnaire could also be used in clinics to improve communication between clinicians and patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06314451
Study type	Observational
Source	University of the West of England
Contact	Joanna C Robson, FRCP PhD
Phone	0117 3427418
Email	jo.robson@uwe.ac.uk
Status	Recruiting
Phase
Start date	June 1, 2022
Completion date	May 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03376204` - Pain Mechanisms in Patients With Bronchiectasis
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Recruiting	`NCT05246098` - REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
Completed	`NCT04467190` - Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
Not yet recruiting	`NCT05374148` - Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
Recruiting	`NCT04502368` - Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
Recruiting	`NCT05775952` - Airway Remodeling and Rhinovirus in Asthmatics
Active, not recruiting	`NCT02681848` - What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Enrolling by invitation	`NCT03319446` - Collection of Anonymized Samples	N/A
Recruiting	`NCT04287959` - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)	N/A
Completed	`NCT05017727` - Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
Completed	`NCT04607330` - Protein Top-up Acceptability Study for Patients With Increased Protein Needs	N/A
Completed	`NCT03334916` - A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients	Phase 4
Completed	`NCT04649736` - Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients	N/A
Completed	`NCT03661801` - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Enrolling by invitation	`NCT03322254` - How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
Recruiting	`NCT03937583` - Screening for Cancer in Patients With Unprovoked VTE	Phase 4
Not yet recruiting	`NCT06026163` - Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress	Phase 2/Phase 3
Completed	`NCT04581096` - Mapping COVID-19 Spread in a Tertiary Hospital

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.